Atlas market file · Equity · United States
GCT Semiconductor Holding, Inc.GCTS
- Last close
- 2.37
- Change
- +4.41%
- 96-bar range
- 1.06 – 3.93
- As of
- 6 Aug 2026
GCT Semiconductor Holding, Inc. is a semiconductors & related devices issuer listed as GCTS on NYSE. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
- Identity
- Nasdaq Trader
- Chart rail
- TradingView
- File state
- Public profile
Static Daily candlestick snapshot from the approved cache, drawn on a labelled price axis: green bodies closed up, red closed down, wicks span each bar's high-to-low range. The live TradingView link stays available; the public profile never embeds a widget that can render the wrong symbol.
▮ up candle ▮ down candle
Weekly outlook: the last 104 weekly closes (-20.74% over the window).
Source rail: Yahoo Finance chart API (GCTS). This dated snapshot is the crawlable Atlas reference.
Live market viewTradingView · provider feed Open view ->
Open the attributed TradingView market view for GCTS. The dated Atlas snapshot above remains the crawlable reference; exchange data in this panel may be live or delayed as labelled by TradingView.
GCTS public profile
Semiconductors & related devices issuer. GCT Semiconductor Holding, Inc. is connected to current market context, cited company sources and its retained research file.
GCT Semiconductor Holding, Inc. trades as GCTS on NYSE. GCT Semiconductor Holding, Inc. (GCTS) has a latest verified close of 2.37, up 4.41%, dated 6 Aug 2026.
Open the chart, inspect attributed company evidence and continue into the fuller research file without losing this market context. Atlas files GCTS under USA Stocks, Technology Stocks and Semiconductor Stocks for browsing.
What changed for GCT Semiconductor Holding, Inc. today
GCT Semiconductor Holding’s March 2026 10-Q shows revenue of $1.9 million, a net loss of $9.9 million, and operating cash burn of $7.4 million in the quarter, leaving cash at $7.2 million and stockholders’ equity at a negative $73.9 million. The company’s product pages boast of 1,900 commercial 5G chipsets shipped in Q4 2025, but the revenue per unit implied by the 10-Q works out to roughly $974 before costs-hardly a sign of volume economics. The gap between the glossy product story and the filed numbers is now too wide to ignore.
GCT sells fabless 4G LTE and 5G NR semiconductor solutions to wireless infrastructure and device makers, operating a single reportable segment focused on chipsets and related development services. The company’s own pages stress “cutting-edge 5G solutions,” yet the 10-Q reveals no customers accounting for more than 10% of revenue in the reported quarter, meaning concentration risk is still unknown territory. The 8-K filed on 18 June 2026 highlights an “at-market” sales agreement with agents that lets GCT issue new shares to fund operations, a structure that keeps dilution on tap rather than on the back foot.
Per the 10-Q for the quarter ended 31 March 2026, revenue from contracts with customers was $1.9 million, net loss attributable to parent was $9.9 million, operating loss was $6.1 million, assets totalled $22.4 million, liabilities $96.3 million, and stockholders’ equity was negative $73.9 million. Cash and equivalents stood at $7.2 million, net cash used in operating activities at $7.4 million, capex at $65,000, R&D expense at $3.2 million, inventory at $1.6 million (up $611,000), and diluted loss per share at $0.15 on 66.1 million diluted shares. The company operates in a single segment without segment-level breakdowns in the filing.
The company’s public pages list “commercial shipments of 5G chipsets exceeded 1,900 units in Q4” and confirm “first commercial shipments of its 5G chipset to lead customers,” but the 10-Q does not break out revenue by product line or customer concentration beyond noting its single operating segment. The SEC submissions JSON and companyfacts JSON confirm the filing index and the absence of additional segment data or customer names. The board’s recent Form 4 filings show six insider sales in early July 2026, underscoring the optics challenge as the company’s equity deficit widens.
For readers looking for a chart, the evidence rail supplied no TradingView route or price data source, so no levels are cited here. GCT trades on the KOSDAQ under no US ticker; the regional exchange is the only venue referenced in the evidence. The company’s product and news pages are the only public-facing rails supplied, and they do not supply revenue bridges, guidance, or forward-looking metrics.
What changed in the last reporting cycle: cash burn accelerated to $7.4 million from operating activities while revenue remained flat near $2 million; inventory rose by $611,000, suggesting slower-than-expected uptake; the board’s “at-market” share sale facility remains the primary liquidity tool; and insider sales continued in July 2026. What remains unproven: whether 5G chipset shipments will translate into sustainable revenue at scale, who the top customers are, whether the company can reduce cash burn below operating inflows, and whether the share issuance facility will be enough to bridge the gap. Evidence that would deepen the file next: a 10-Q or 8-K disclosing customer concentration, a revenue bridge by product line, a formal reduction-in-force or restructuring plan, or an equity raise outside the existing sales agreement that doesn’t dilute existing shareholders further.
Sources & evidence · 10 links
This is the public answer layer. The full Atlas report adds the complete Market Wit archive, risk rail, catalyst map, final editor synthesis, PDF/CSV export, email delivery and saved history.
GCTS technical readout
Directional bias down. Wilder ADX and ATR computed from Atlas approved daily OHLC through 2026-07-28. Indicators are descriptive statistics, not investment advice.
Open an Atlas research path on GCTS
FreedomCore Atlas can expand this public profile into source-led research files with company snapshots, valuation context, filings and segment detail, source packs, and equity briefs. Each path keeps the underlying public sources visible.
Open Atlas workstation ->Keep GCTS research in your Atlas archive
Free Atlas includes the public profile and one owned welcome research artifact after account setup. Atlas Pro adds up to 25 custom research runs a day, a 500-symbol watchlist, saved report versions, and eligible PDF, CSV, and email artifacts. Evidence holds still apply and never become an unverified download. £12/month founding price, locked for life. Research only; not investment advice.
Checking Atlas access...
GCTS FAQ
What is GCT Semiconductor Holding, Inc. (GCTS)?GCT Semiconductor Holding, Inc. (GCTS) has a latest verified close of 2.37, up 4.41%, dated 6 Aug 2026. Use this page to check the price chart, company context,...
GCT Semiconductor Holding, Inc. (GCTS) has a latest verified close of 2.37, up 4.41%, dated 6 Aug 2026. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
What does Atlas show for GCTS?GCT Semiconductor Holding, Inc. (GCTS) has a latest verified close of 2.37, up 4.41%, dated 6 Aug 2026. It brings the latest available chart, company context, cited...
GCT Semiconductor Holding, Inc. (GCTS) has a latest verified close of 2.37, up 4.41%, dated 6 Aug 2026. It brings the latest available chart, company context, cited sources, risks and the route into the full Atlas research file together. Atlas files GCTS under USA Stocks, Technology Stocks and Semiconductor Stocks for browsing.
How often is the GCTS page updated?The GCTS public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the...
The GCTS public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the freshness of the current market snapshot.
Which sources does Atlas use for GCTS?The GCTS file starts with SEC EDGAR filings, Nasdaq Trader and TradingView NYSE:GCTS. SEC EDGAR provides the filing anchor for this issuer. The page separates verified...
The GCTS file starts with SEC EDGAR filings, Nasdaq Trader and TradingView NYSE:GCTS. SEC EDGAR provides the filing anchor for this issuer. The page separates verified market context from company evidence and shows open evidence gaps instead of filling them with assumptions.
Can Atlas run a full research brief on GCTS?Yes. The workstation can open GCTS, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Yes. The workstation can open GCTS, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Is this GCTS page investment advice?No. The GCTS page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise...
No. The GCTS page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise of returns.
Methodology
This profile is generated daily from public sources including SEC EDGAR (US-listed companies), NASDAQ Trader files, exchange listings, public macro/central-bank releases, CoinGecko crypto market files where relevant, and the TradingView global symbol catalog. Multi-model AI may assist drafting and review where configured, but sources remain the evidence rail; the chart is an Atlas static OHLC rail with a live TradingView link when verified bars are available; otherwise the page keeps the verified TradingView route as an explicit fallback.
Research only. Not investment advice. No brokerage execution. No guaranteed returns are promised or implied. FreedomCore does not provide personalised investment advice. Always consult a regulated financial advisor before making investment decisions.
Profile last updated: 2026-08-07. Browse FreedomCore Atlas research notes →
GCTS
Equity · evidence first